SMTL ID : 2bzs.1

Binding of anti-cancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structure of their complex.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

2 x ZN: ZINC ION(Non-covalent)

ZN.1: 3 residues within 4Å: Chain A: H.179, H.183, C.228 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.179, A:H.183, A:C.228, A:C.228 ZN.4: 3 residues within 4Å: Chain B: H.179, H.183, C.228 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:H.179, B:H.183, B:C.228, B:C.228

2 x FAD: FLAVIN-ADENINE DINUCLEOTIDE(Non-covalent)

FAD.2: 27 residues within 4Å: Chain A: N.72, Y.73, G.74, D.123 Chain B: H.17, K.21, S.22, F.23, N.24, S.26, P.108, L.109, Y.110, W.111, F.112, T.153, T.154, G.155, G.156, Y.161, P.198, E.199, E.203, R.206, K.207, V.210 Ligands: CB1.3 24 PLIP interactions: 22 interactions with chain B, 2 interactions with chain A Hydrophobic interactions: B:Y.110, B:Y.110, B:Y.110, A:Y.73 Hydrogen bonds: B:F.23, B:N.24, B:N.24, B:S.26, B:S.26, B:L.109, B:L.109, B:W.111, B:F.112, B:T.153, B:T.153, B:G.155, B:G.156, B:Y.161, B:Y.161, B:R.206 Salt bridges: B:H.17 pi-Stacking: B:F.23, B:F.23 Water bridges: A:N.72 FAD.5: 26 residues within 4Å: Chain A: H.17, K.21, S.22, F.23, N.24, S.26, P.108, L.109, Y.110, W.111, F.112, T.153, T.154, G.155, G.156, Y.161, P.198, E.199, E.203, R.206, K.207 Chain B: N.72, Y.73, G.74, D.123 Ligands: CB1.6 23 PLIP interactions: 21 interactions with chain A, 2 interactions with chain B Hydrophobic interactions: A:Y.110, A:Y.110, A:Y.110, B:Y.73 Hydrogen bonds: A:F.23, A:N.24, A:N.24, A:S.26, A:S.26, A:L.109, A:L.109, A:W.111, A:F.112, A:T.153, A:T.153, A:G.155, A:G.156, A:Y.161, A:E.199, A:R.206 Water bridges: A:E.199, B:N.72 Salt bridges: A:H.17

2 x CB1: 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE(Non-covalent)

CB1.3: 9 residues within 4Å: Chain A: F.132, F.184 Chain B: W.111, F.112, G.155, G.156, M.160, N.167 Ligands: FAD.2 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:F.184 CB1.6: 8 residues within 4Å: Chain A: W.111, G.155, G.156, M.160, N.167 Chain B: F.132, F.184 Ligands: FAD.5 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:G.155 Hydrophobic interactions: B:F.184

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Abu Khader, M.M. et al., Binding of the Anticancer Prodrug Cb1954 to the Activating Enzyme Nqo2 Revealed by the Crystal Structure of Their Complex. J.Med.Chem. (2005)

Release Date

2005-09-23

Peptides

NRH DEHYDROGENASE [QUINONE] 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

NRH DEHYDROGENASE [QUINONE] 2